Warning Letters: FDA Warns Drugmakers in China and Germany By Sam | March 3, 2020 The FDA issued warning letters to drug manufacturing facilities in China and Germany for lax testing, recordkeeping and other failures. Source: Drug GMP Report Posted in Drug GMP Report